Current stock page

Catalysts

PRGO Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - Specialty & GenericScore data as of Sep 4, 2026

PRGO

Catalysts
Perrigo Company plc
Healthcare· Drug Manufacturers - Specialty & Generic
AIQ Score
NeutralAIQ Edge 7/10
Low Priority
Above Peers
Score data as of Sep 4, 2026
Last price
$14.92
+$0.65 (+4.56%)
Latest market quote
Momentum78
Value74
Quality25
Risk Resilience48
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Nov 4, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 56/100

Momentum 78/100 and sentiment before the next covered event.

Recent coverage
2 articles

Updated Sep 5, 2026 · Sentiment 59.20%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 78/100AIQ Edge 7/10 Above Peers
Beat rate
63%
5 of 8 reported periods
Average surprise
+5.7%
Across covered historical reports
Latest result
+28.9%
Aug 5, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 5, 2026$0.39$0.50+28.9%$1.02B$1.02B
May 6, 2026$0.39$0.43+10.3%$1.04B$969.2M
Feb 26, 2026$0.80$0.77-3.8%$1.1B$1.11B
Nov 5, 2025$0.75$0.80+6.7%$1.09B$1.04B
Aug 6, 2025$0.59$0.57-3.4%$1.1B$1.06B
May 7, 2025$0.56$0.60+7.1%$1.08B$1.04B
Feb 27, 2025$0.92$0.93+1.1%$1.09B$1.14B
Nov 6, 2024$0.82$0.81-1.2%$1.2B$1.09B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
2
Buy
3
Hold
12-month analyst target
$20.00
+34.05% versus current price
Based on 1 analyst observations. Targets are estimates, not predictions.
Low target
$20.00
+34.05% vs latest price
Average target
$20.00
+34.05% vs latest price
High target
$20.00
+34.05% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateNov 4, 2026

Next known earnings or reporting date.

EPS estimate$0.52

Current analyst expectation for the upcoming report.

Revenue estimate$991.53M

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score78

Where event reaction would show up first.

AIQ score56/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
1
Average target
$20.00
Target upside
34.05%
Target range
$20.00 - $20.00
90-day revisions
42

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
0
Negative
0
rttnews.com · Aug 6, 2026

Top Biotech Gainers: ATTO Debuts, AMWL Cuts Loss, PRGO Returns To The Black, URGN Hits New High

Today's top biotech gainers include Attovia Therapeutics, which surged following its Nasdaq debut; American Well, after reporting a narrower loss; Perrigo, which swung back to profit; and UroGen Pharma, following strong second-quarter financial results, among others.

seekingalpha.com · Jun 12, 2026

Perrigo Company: Expected Improvement In Latter Part Of FY26 Doing Little For Investors

Perrigo stock: why it’s still a hold despite a double-digit dividend yield, falling Q1 revenue, and an execution-risk 2026 outlook. Click here to read more.

Open full news and sentiment

PRGO Catalysts FAQ

What are the next catalysts for PRGO stock?

PRGO's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move PRGO stock?

Upcoming events that could move PRGO include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could PRGO's next earnings report affect the stock?

PRGO's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive PRGO stock higher?

PRGO could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt PRGO stock?

PRGO could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.